|
1171 |
Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]
Enthalten in BMC complementary and alternative medicine Bd. 18, 22.1.2018, Nr. 1, date:12.2018: 1-12
|
|
|
|
1172 |
Clinical drug trials in general practice: how well are external validity issues reported?
Enthalten in BMC family practice Bd. 18, 29.12.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
1173 |
Clinical features of Parkinson’s disease patients are associated with therapeutic misconception and willingness to participate in clinical trials
Enthalten in Trials Bd. 18, 29.9.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
1174 |
Clinical interventions, implementation interventions, and the potential greyness in between -a discussion paper
Enthalten in BMC health services research Bd. 17, 7.1.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
1175 |
Clinical research
Enthalten in Journal of general internal medicine Bd. 1, 9.1.2018, Nr. 3, date:5.1986: 203-204
|
|
|
|
1176 |
Clinical research and medical care: towards effective and complete integration
Enthalten in BMC medical research methodology Bd. 15, 9.1.2015, Nr. 1, date:12.2015: 1-7
|
|
|
|
1177 |
Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review
Enthalten in Implementation science Bd. 12, 5.1.2017, Nr. 1, date:12.2017: 1-14
|
|
|
|
1178 |
Comment on “Patient Reporting in the EU: Analysis of EudraVigilance Data”
Enthalten in Drug safety Bd. 40, 4.7.2017, Nr. 10, date:10.2017: 935-936
|
|
|
|
1179 |
Commentary: considerations for using the ‘Trials within Cohorts’ design in a clinical trial of an investigational medicinal product
Enthalten in Trials Bd. 19, 8.1.2018, Nr. 1, date:12.2018: 1-6
|
|
|
|
1180 |
Comparative costs and activity from a sample of UK clinical trials units
Enthalten in Trials Bd. 18, 2.5.2017, Nr. 1, date:12.2017: 1-11
|
|
Administration
